Mohit Kaushal
Independent DirectorDr. Mohit Kaushal, also known as Mo, Ph.D., M.D., Master of Business Administration, serves as Senior Advisor at General Atlantic Service Company, L.P., where Dr. Kaushal started as a consultant in 2014 and was a Special Advisor since 2015. Dr. Kaushal provides strategic support and advice to the firm’s investment teams and portfolio companies in the Healthcare sector. Dr. Kaushal works closely with General Atlantic's Healthcare sector to identify new investment opportunities and to provide strategic support for its portfolio companies. Dr. Kaushal serves as Independent Director at Gravie, Inc. since 2025. Dr. Kaushal serves as Non-Executive Director at Emyria Limited since August 21, 2023. Dr. Kaushal serves as Director at SCP and CO Healthcare Acquisition Company since August 17, 2021. Dr. Kaushal serves as Independent Director at Starling Oncology, Inc. since March 10, 2020. Dr. Kaushal serves as Independent Director at DFP Healthcare Acquisitions Corp. since March 10, 2020. Dr. Kaushal has been Independent Director at Oak Street Health, Inc since 2018. Dr. Kaushal has been a Director of DFB Healthcare Acquisitions Corp. since February 15, 2018. Dr. Kaushal is a Scholar in Residence at the Duke Margolis Center for Health Policy since 2016. Dr. Kaushal is an Adjunct Professor at Stanford University since 2014, with a joint position within the newly created Biomedical Data Science Department and medical school's Clinical Excellence Research Center. Dr. Kaushal serves as a member of Advisory Board at ACES 2020, LLC. Dr. Kaushal is an Investment Professional at California HealthCare Foundation. Dr. Kaushal is an Adjunct Assistant Professor of Emergency Medicine at George Washington University, with a focus on connected health clinical research. Dr. Kaushal serves on the curation team at TEDMED. Dr. Kaushal is an ER physician. Dr. Kaushal is a Board Member of Array Behavioral Health. Dr. Kaushal is a Member of the Johns Hopkins University Biomedical Engineering Industrial Liaison Advisory Board. Dr. Kaushal is a Board member of Rxante. Dr. Kaushal was a Member of Advisory Board at Saama Technologies, Inc. until 2022. Dr. Kaushal was a Director of Gravie, Inc. from March 2014 until 2025. Dr. Kaushal was a Director of CitiusTech Inc. from August 24, 2016 until October 2019. Dr. Kaushal was an Independent Director of Universal American Corp from August 17, 2016 to April 28, 2017. Dr. Kaushal was a Partner of Aberdare Ventures from April 16, 2013 until 2014. Dr. Kaushal was Chief Strategy Officer and Executive Vice President of Business Development at The Gary and Mary West Health Institute from 2010 to 2013. Dr. Kaushal identified and pursued business development opportunities to advance Gary and Mary West Wireless Health Institute's mission of lowering health care costs. Dr. Kaushal also developed and executed strategies to accelerate the availability of wireless health solutions to patients and families. Dr. Kaushal was Co-Manager of The West Health Investment Fund. Dr. Kaushal was Chief Strategy Officer and Executive Vice President of Business Development at West Health Investment Fund from 2010 to 2013. Dr. Kaushal was an inaugural Executive Vice President of Business Development and Chief Strategy Officer at West Health Institute. Dr. Kaushal was Director of Connected Health at Federal Communications Commission. Dr. Kaushal established the agency's first dedicated health care team and Dr. Kaushal's team initiated collaboration with the Food and Drug Administration for the regulatory streamlining of converged telecommunications, data analytics and medical devices leading to the release of the mobile medical applications guidance by the FDA. In addition, Dr. Kaushal's team reformed the Rural Healthcare fund to create the Healthcare Connect Fund, which aligned the funding mechanism with wider healthcare payment policy and technology reform. Dr. Kaushal was a Member of the White House Health IT task force during the Obama Administration. Dr. Kaushal was a member of a cross agency team implementing the technology aspects of the Accountable Care Act and testified to Congress on the application of technology and payment reform to the Medicare population. Dr. Kaushal was a Fund Manager at California HealthCare Foundation, Inc. Dr. Kaushal was an Investment Professional at Polaris Venture Partners. Dr. Kaushal held roles with Merrill Lynch's Health Care Investment Banking Group and the World Health Organization. Dr. Kaushal was a Visiting Scholar at the Brookings Institution. Dr. Kaushal was a Member of Advisory Board at Arboretum Ventures LLC. Dr. Kaushal was a Member of the Board of Directors at The West Health Investment Fund. Dr. Kaushal led several investments including Humedica, Rxante, Change Healthcare, goBalto, Wellframe and Gravie. Dr. Kaushal received a Master of Business Administration from Stanford Graduate School of Business. Dr. Kaushal received a Doctor of Medicine with distinction and a Bachelor of Science from the Imperial College of Science, Technology and Medicine.
Positions
- Company NameStarling Oncology, Inc.Stock CodeSTLNPositionIndependent DirectorColleagues
- DVDaniel VirnichCEO & Executive Director
- AMAnne M. McGeorgeIndependent Chairman
- RCRobert CarterChief Financial Officer
- YDYale D. PodnosChief Medical Officer
- ALAustin LeeVP of Accounting & Controller
- RPRakesh PandaChief Information Officer
- KMKaren Marie Walker JohnsonIndependent Director
- MDMark D. StolperIndependent Director
